Phio Pharmaceuticals Presents New Data for Targeting of BRD4 with its INTASYL™ Compound PH-894

<p>–Preclinical data shows melanoma cells treated with PH-894 makes them more recognizable to immune cells, increasing potential for elimination –Preclinical data demonstrates the effectiveness of PH-894 as an antitumor cytotoxic agent (directly killing tumor cells) –Data to be presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston on October 11th-15th MARLBOROUGH, […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/phio-pharmaceuticals-presents-new-data-for-targeting-of-brd4-with-its-intasyl-compound-ph-894/">Phio Pharmaceuticals Presents New Data for Targeting of BRD4 with its INTASYL™ Compound PH-894</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>